More on SLS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.34 |
|
|||
| Open | $11.20 | ||||
| 52 Wk High | $10.16 | ||||
| 52 Wk Low | $6.52 | ||||
| Day High | $11.24 | ||||
| Day Low | $9.75 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 15,823,285 | ||||
- Sellas presents preclinical SLS009 pancreatic cancer data at AACR
- SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
- Communities Finalise Life Plans Alongside Renewed Shuar Agreements as Warintza Continues to Advance De-Risking Activities
- SELLAS Life Sciences Group, Inc. (SLS) Reports In-Line Q2 EPS
- Form 8-K SELLAS Life Sciences For: Aug 11
- SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Form 10-Q SELLAS Life Sciences For: Jun 30
- Form SCHEDULE 13G SELLAS Life Sciences Filed by: STATE STREET CORP
- Ecuador's Mining Reset Is Opening Doors. Salazar Resources Is Walking Through All of Them
- Form SCHEDULE 13G SELLAS Life Sciences Filed by: VANGUARD CAPITAL MANAGEMENT LLC
Entities mentioned with SLS
- FDA | View Related Stories »
- S3 | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maxim Group | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
